spacer spacer spacer
Home spacer DHSS Home spacer State Home spacer Disclaimer
DHSS Header spacer spacer
Report Suspected Biological, Chemical or Radiological Terrorism Events by Calling 1-800-392-0272  (24 hours a day - 7 days a week)
  Questions? Ask Us. spacer
Biological Threat
  For The General Public
  For Medical Professionals
Chemical Threat
  For The General Publicspacer
  For Medical Professionals
Radiological/Nuclear Threat
  For The General Public
  For Medical Professionals
Pandemic Influenza
Natural Disaster
Mass Trauma
Children and Disaster Terrorism
Disaster Mental
Health
  How To Handle Situations Involving Suspicious Powdery Substances  
Missouri Hospitals
Local Public Health Agencies
spacer About the Center for Emergency Response & Terrorism spacer
      
     
     
spacer    
spacer   spacer
spacer   spacer
      
spacer    
Gradient Image
  

Biological Threat

Emergency Response and Terrorism

Information for Medical Professionals


Category A Diseases/Agents (See definition)

Category B Diseases/Agents (See definition)

Category C Diseases/Agents (See definition)



Category Definitions

The U.S. public health system and primary healthcare providers must be prepared to address various biological agents, including pathogens that are rarely seen in the United States.

Category A Diseases/Agents

High-priority agents include organisms that pose a risk to national security because they

  • can be easily disseminated or transmitted from person to person;
  • result in high mortality rates and have the potential for major public health impact;
  • might cause public panic and social disruption; and
  • require special action for public health preparedness.

Category B Diseases/Agents

Second highest priority agents include those that

  • are moderately easy to disseminate;
  • result in moderate morbidity rates and low mortality rates; and
  • require specific enhancements of CDC's diagnostic capacity and enhanced disease surveillance.

Category C Diseases/Agents

Third highest priority agents include emerging pathogens that could be engineered for mass dissemination in the future because of

  • availability;
  • ease of production and dissemination; and
  • potential for high morbidity and mortality rates and major health impact.

For more information on the agent/disease selection and prioritization process, see Rotz LD, Khan AS, Lillibridge SR, et all. Public health assessment of potential biological terrorism agents. Emerg Infect Dis 2002; 8(2):225-30. http://www.cdc.gov/ncidod/eid/vol8no2/01-0164.htm